Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- As diabetes technologies advance, matching patients to the ‘right’ device challenges providers
-
- Apple research app to begin tracking menstrual cycles for women’s health studies
- Weight loss recommended to decrease CV risk in metabolically healthy obesity
- Bariatric surgery unsuccessful in Prader-Willi syndrome
- Even small BP elevation during pregnancy may predict future hypertension
- Gender-affirming HT alters body composition during adolescence
- Hypogonadism, hypocortisolism common in chronic opioid use
- Likelihood of type 2 diabetes remission heightened with earlier modest weight loss
- Long-acting pasireotide provides ‘sustained biochemical improvements’ in Cushing’s disease
-
- CONCLUDE: ‘Uncertainties’ complicate hypoglycemia findings comparing insulin degludec vs. glargine
- Cost for osteoporosis care rose 118% over 15 years in US
- ‘Digiceuticals,’ new CGM devices, HbA1c alternatives transform diabetes management
- Four strategies to obtain affordable insulin
- Lifestyle changes as important as medication to prevent, treat type 2 diabetes
- Semaglutide injection bests canagliflozin, liraglutide in head-to-head type 2 diabetes trials
- Is CGM use appropriate for people with non-insulin-dependent type 2 diabetes?